Blar i forfatter Det helsevitenskapelige fakultet "Fadnes, Bodil Irene"

Viser treff 1-3 av 3

    • The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells 

      Fadnes, Bodil Irene; Rekdal, Øystein; Uhlin-Hansen, Lars (Journal article; Tidsskriftartikkel; Peer reviewed, 2009-06-15)
      Background: Cationic antimicrobial peptides (CAPs) with antitumor activity constitute a promising group of novel anticancer agents. These peptides induce lysis of cancer cells through interactions with the plasma membrane. It is not known which cancer cell membrane components influence their susceptibility to CAPs. We have previously shown that CAPs interact with the two glycosaminoglycans (GAGs), ...

    • The proteoglycan repertoire of lymphoid cells 

      Fadnes, Bodil Irene; Husebekk, Anne; Svineng, Gunbjørg; Rekdal, Øystein; Yanagishita, Masaki; Kolset, Svein Olav; Uhlin-Hansen, Lars (Journal article; Tidsskriftartikkel; Peer reviewed, 2012)
      Proteoglycans have been studied to a limited extent in lymphoid cells. In this study we have investigated the expression of proteoglycans in B-cells, CD4+ T-cells, CD8+ T-cells, natural killer cells, as well as in nine different cell lines established from patients with lymphoid malignancies. Serglycin was the major proteoglycan expressed at mRNA level by the primary lymphocytes. None of the syndecans ...

    • Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells 

      Fadnes, Bodil Irene; Uhlin-Hansen, Lars; Lindin, Inger; Rekdal, Øystein (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)
      Several naturally occurring cationic antimicrobial peptides (CAPs), including bovine lactoferricin (LfcinB), display promising anticancer activities. These peptides are unaffected by multidrug resistance mechanisms and have been shown to induce a protective immune response against solid tumors, thus making them interesting candidates for developing novel lead structures for anticancer treatment. ...